Shimadzu Diagnostics Corporation (formerly Nissui Pharmaceutical Co., Ltd., hereinafter “SDC”), a Shimadzu subsidiary with development and manufacturing capabilities in the clinical sector, has invested approximately 50 million yen in MiCAN Technologies, Inc. (Head Office: Kyoto City, hereinafter “MiCAN”), a biotechnology venture specializing in regenerative medicine, in addition to approximately 20 million yen invested in MiCAN […]

Introduction of a FFPE workflow extends the tissue proteomics applications of PreOmics’ unique BeatBox™ technology Launch of novel FFPE workflow enables high-throughput, robust and fast processing of tissue samples Bruker and PreOmics to co-commercialize BeatBox workflows ORLANDO, Fla. — At the AACR Annual Meeting 2023, PreOmics GmbH announced the launch of a BeatBox-based FFPE workflow, which simplifies, […]

Oxford Nanopore Technologies and bioMérieux SA, a world leader in the field of in vitro diagnostics, today announced that they have teamed up to improve health outcomes globally by exploring selected opportunities to bring nanopore sequencing to the infectious disease diagnostics market.  The companies are jointly exploring selected opportunities to advance patient care by providing […]

ARCHIMED first bought 90 percent of Polyplus in 2016, and moved to co-lead the partnership with Warburg Pincus in 2020, after selling half of ARCHIMED’s stake for a 70x multiple on invested capital. With the agreement to sell Strasbourg, France-based Polyplus for €2.4 billion ($2.6 billion), to listed Sartorius Stedim Biotech S.A. (DIM: EN Paris), […]

SureSelect Cancer CGP assay expands the number of biomarkers for solid tumor profiling with a fast and highly efficient workflow SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent SureSelect Cancer CGP Assay designed for somatic variant profiling for a broad range of solid tumor types. The pan-cancer assay design is […]

TCR and CAR libraries enable comprehensive screening of combinations of custom gene parts including domains from TCRs and CARs Information about the offering available at AACR Annual Meeting 2023 SOUTH SAN FRANCISCO, Calif. —  Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, […]

biomodal (formerly known as Cambridge Epigenetix) commercially launches its new duet multiomics solution, revealing the combinatorial power of genetic and epigenetic information from a single low volume sample. The duet multiomics solution clearly illustrates novel data modalities to empower a range of applications, starting with input from 10ng of cell-free DNA biomodal recently published the solution […]

Oxford Instruments plc, which provides high-technology products and systems to the world’s leading companies and scientific research communities, has today announced the forthcoming retirement, with the agreement of the Board, of Chief Executive Ian Barkshire, who will leave after seven years as Chief Executive and more than 25 years with the company.  Richard Tyson, currently […]

Enable Cloud Platform to be Available with Canopy CellScape System for High-Plex Spatial Biology ST. LOUIS & MENLO PARK, Calif. — Canopy Biosciences, a Bruker Company, and Enable Medicine, today announced a partnership to provide Enable Medicine’s advanced analysis pipelines for spatial omics data with the Canopy CellScape™ system for quantitative high-plex spatial biology. The partnership […]

Innovative AI-powered interpretation methods to meet the future needs of precision medicine SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced a strategic partnership with PathAI, a leading provider of AI-powered research tools and services for pathology, to deliver biopharmaceutical organizations a solution that combines Agilent’s assay development expertise and PathAI’s algorithm development capabilities. By […]